Found 11 matching trials
Two-month Regimens Using Novel Combinations to Augment Treatment Effectiveness for Drug-sensitive Tuberculosis PHASE2 The current standard management strategy for drug-sensitive pulmonary tuber...
Show More Location
National Institute of TB and Respiratory Diseases
Learn More & Join Trial
Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis With Clofazimine (C)-TMC207 (J)-PA-824 (Pa)-Pyrazinamide (Z) PHASE2 The trial will evaluate the extended bactericidal activity of 14 consecutiv...
Show More Location
Centre for Tuberculosis Research Innovation, UCT Lung Institute
Learn More & Join Trial
Clofazimine- and Rifapentine-Containing Treatment Shortening Regimens in Drug-Susceptible Tuberculosis: The CLO-FAST Study PHASE2 The purpose of this study was to compare a 3-month rifapentine (RPT)/clofaz...
Show More Location
Les Centres GHESKIO Clinical Research Site (GHESKIO-INLR) CRS
Learn More & Join Trial
Randomized Controlled Multi-center Short Course Treatment for Rifampicin Resistant Tuberculosis NA This study is a randomized, controlled, multi-center clinical study. The ma...
Show More Location
Beijing Chest Hospital affiliated to Capital Medical University
Learn More & Join Trial
Finding the Optimal Regimen for Mycobacterium Abscessus Treatment PHASE2 Mycobacterium abscessus (MABS) is a group of rapid-growing, multi-drug resi...
Show More Location
St George Hospital
Learn More & Join Trial
Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform Trial PHASE2 The goal of this clinical trial is to learn if a new combination antibiotic...
Show More Location
Multiple Locations
Learn More & Join Trial
NGS-Guided(G) Regimens(R) of Anti-tuberculosis(A) Drugs for the Control(C) and Eradication(E) of MDR-TB NA Tuberculosis (TB) has been one of the top 10 causes of death worldwide from...
Show More Location
The Third People's Hospital of Shenzhen City
Learn More & Join Trial
Innovating(IN) Shorter(S), All- Oral, Precised(P), Individualized(I) Treatment Regimen(RE) for Rifampicin Resistant Tuberculosis(INSPIRE-TB) PHASE3 The INSPIRE-TB study is a pragmatic, multicentre, randomised, controlled, n...
Show More Location
Guiyang Public Health Treatment Center
Learn More & Join Trial
Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis:BDLL Chinese Cohort PHASE3 This is an investigational, prospective, multicenter, single-arm, open labe...
Show More Status
Active Not Recruiting
Location
Anhui Chest Hospital
Learn More & Join Trial
A Phase 2b Clinical Study of JDB0131 Benzenesulfonate Tablets PHASE2 This is a multicenter, randomized, open-label, active-controlled clinical s...
Show More Location
Wuhan Pulmonary Hospital
Learn More & Join Trial